Article Information
PubMed
Print ISSN
Online ISSN
History
- Received August 7, 2020
- Accepted December 14, 2020
- Published online February 19, 2021.
Article Versions
- Earlier version (December 16, 2020 - 09:23).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2021 by The Author(s) This is an open access article distributed under the CC BY-NC Attribution 4.0 International license.
Author Information
- Jaromir Vlach1,
- Andrew T. Bender1,
- Melinda Przetak,
- Albertina Pereira,
- Aditee Deshpande,
- Theresa L. Johnson,
- Sonja Reissig,
- Evgeni Tzvetkov,
- Djordje Musil,
- Noune Tahmassian Morse,
- Philipp Haselmayer,
- Simone C. Zimmerli,
- Shinji L. Okitsu,
- Robert L. Walsky, and
- Brian Sherer
- EMD Serono (a business of Merck KGaA, Darmstadt, Germany), Billerica, Massachusetts (J.V., A.T.B., M.P., A.P., A.D., T.J., E.T., N.T.M., S.F.Z., S.L.O., R.W., B.S.) and Merck KGaA, Darmstadt, Germany (S.R., D.M., P.H.)
- Address correspondence to:
Andrew T. Bender, EMD Serono, 45A Middlesex Turnpike, Billerica, MA 01821. E-mail: andrew.bender{at}emdserono.com
Statistics from Altmetric.com
Article usage
In this issue
M5049: A Novel Selective Toll-Like Receptor 7/8 Inhibitor
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement